Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial
Rasmussen, Birgitte B, Dr, Regan, Meredith M, ScD, Lykkesfeldt, Anne E, PhD, Dell'Orto, Patrizia, ScD, Del Curto, Barbara, ScD, Henriksen, Katrine L, MSc, Mastropasqua, Mauro G, MD, Price, Karen N, BS, Méry, Eliane, MD, Lacroix-Triki, Magali, MD, Braye, Stephen, MD, Altermatt, Hans J, MD, Gelber, Richard D, Prof, Castiglione-Gertsch, Monica, Prof, Goldhirsch, Aron, Prof, Gusterson, Barry A, Prof, Thürlimann, Beat, Prof, Coates, Alan S, Prof, Viale, Giuseppe, Prof
Published in The lancet oncology (2008)
Published in The lancet oncology (2008)
Get full text
Journal Article